FDA.report

Ciprofloxacin

Product NDC
68788-8200
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ciprofloxacin
Dosage form
TABLET, COATED
Route
ORAL
Labeler
Preferred Pharmaceuticals Inc.
Application
ANDA208921
Marketing category
ANDA
Substance
CIPROFLOXACIN HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
68788-8200-110 TABLET, COATED in 1 BOTTLE (68788-8200-1) 2022-05-24NoHistorical
68788-8200-220 TABLET, COATED in 1 BOTTLE (68788-8200-2) 2022-05-24NoHistorical
68788-8200-330 TABLET, COATED in 1 BOTTLE (68788-8200-3) 2022-05-24NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN TABLETS, for oral use Initial U.S. Approval: 1987Preferred Pharmaceuticals Inc.2026-03-27HUMAN PRESCRIPTION DRUG LABEL5